BGNE - BeiGene Ltd - ADR
IEX Last Trade
191.6
-6.900 -3.601%
Share volume: 293,387
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$198.50
-6.90
-3.48%
Summary score
22%
Profitability
25%
Dept financing
9%
Liquidity
52%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.72%
Return on assets
-6.21%
Return on sales
-191.81%
Return on invested capital
1272.46%
Total debt ratio
31.97%
Debt ratio change over timeo
-0.94%
Current Ratio
4.17%
Quick Ratio
4.01%
Cash Position Ratio
3.68%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-5.54%
Return on assets
-4.8%
Return on sales
-41.49%
Return on invested capital
246.82%
Total debt ratio
36.34%
Debt ratio change over timeo
-0.81%
Current Ratio
2.67%
Quick Ratio
2.44%
Cash Position Ratio
2.05%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-7.47%
Return on assets
-4.61%
Return on sales
-34.77%
Return on invested capital
206.27%
Total debt ratio
40.71%
Debt ratio change over time
-0.77%
Current Ratio
2.08%
Quick Ratio
1.84%
Cash Position Ratio
1.48%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.93%
Return on assets
-104.35%
Return on sales
-220.91%
Return on invested capital
42.35%
Total debt ratio
-94.4%
Debt ratio change over time
-0.94%
Current Ratio
-0.46%
Quick Ratio
-0.53%
Cash Position Ratio
-0.62%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BGNE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.72% | 13.79% | 34.47% | 7.43% |
| Return on assets | -6.21% | 2.76% | 3.15% | 5.62% |
| Return on sales | -191.81% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 1272.46% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 59% | 56% |
| Total debt ratio | 31.97% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.94% | 308.97% | -6.99% | 1.18% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 2.67% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.44% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.05% | 0.36% | 1.28% | 2.93% |
| Liquididy | 74% | 12% | 27% | 62% |
| Short-term ratios | BGNE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -5.54% | 13.77% | 13.25% | 3.8% |
| Return on assets | -4.8% | 2.43% | 1.89% | 3.09% |
| Return on sales | -41.49% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 246.82% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 36.34% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.81% | 46.38% | -72.08% | 1.51% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 2.67% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.44% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.05% | 0.36% | 1.28% | 2.93% |
| Liquididy | 43% | 12% | 31% | 75% |